Synopsis
Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Molecular Weight | 398.4 g/mol |
---|---|
Molecular Formula | C18H14N4O5S |
XLogP3 | 2.3 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 6 |
Exact Mass | 398.06849073 g/mol |
Monoisotopic Mass | 398.06849073 g/mol |
Topological Polar Surface Area | 146 A^2 |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 804 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 6 | |
---|---|
Drug Name | Azulfidine |
PubMed Health | Salicylate (Oral route, Rectal route) |
Drug Classes | Antirheumatic, Gastrointestinal Agent |
Drug Label | AZULFIDINE EN-tabs Tablets contain sulfasalazine, formulated in a delayed release tablet (enteric-coated), 500 mg, for oral administration.AZULFIDINE EN-tabs Tablets are film coated with cellulose acetate phthalate to retard disintegration of the tab... |
Active Ingredient | Sulfasalazine |
Dosage Form | Tablet; Suspension |
Route | Oral |
Strength | 500mg; 250mg/5ml |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
2 of 6 | |
---|---|
Drug Name | Azulfidine en-tabs |
PubMed Health | Sulfasalazine (By mouth) |
Drug Label | AZULFIDINE EN-tabs Tablets contain sulfasalazine, formulated in a delayed release tablet (enteric-coated), 500 mg, for oral administration.AZULFIDINE EN-tabs Tablets are film coated with cellulose acetate phthalate to retard disintegration of the tab... |
Active Ingredient | Sulfasalazine |
Dosage Form | Tablet; Tablet, delayed release |
Route | oral; Oral |
Strength | 500mg |
Market Status | Prescription |
Company | Pharmacia Upjohn; Pharmacia And Upjohn |
3 of 6 | |
---|---|
Drug Name | Sulfasalazine |
Drug Label | Sulfasalazine Tablets USP, 500 mg for Oral AdministrationTherapeutic classification: Anti-inflammatory agent.Chemical designation: 5-[[p-(2-Pyridylsulfamoyl)phenyl]azo]salicylic acid.Chemical Structure:The molecular weight of sulfasalazine is 398.39.... |
Active Ingredient | Sulfasalazine |
Dosage Form | Tablet; Tablet, delayed release |
Route | Oral |
Strength | 500mg |
Market Status | Prescription |
Company | Vintage Pharms; Watson Labs |
4 of 6 | |
---|---|
Drug Name | Azulfidine |
PubMed Health | Salicylate (Oral route, Rectal route) |
Drug Classes | Antirheumatic, Gastrointestinal Agent |
Drug Label | AZULFIDINE EN-tabs Tablets contain sulfasalazine, formulated in a delayed release tablet (enteric-coated), 500 mg, for oral administration.AZULFIDINE EN-tabs Tablets are film coated with cellulose acetate phthalate to retard disintegration of the tab... |
Active Ingredient | Sulfasalazine |
Dosage Form | Tablet; Suspension |
Route | Oral |
Strength | 500mg; 250mg/5ml |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
5 of 6 | |
---|---|
Drug Name | Azulfidine en-tabs |
PubMed Health | Sulfasalazine (By mouth) |
Drug Label | AZULFIDINE EN-tabs Tablets contain sulfasalazine, formulated in a delayed release tablet (enteric-coated), 500 mg, for oral administration.AZULFIDINE EN-tabs Tablets are film coated with cellulose acetate phthalate to retard disintegration of the tab... |
Active Ingredient | Sulfasalazine |
Dosage Form | Tablet; Tablet, delayed release |
Route | oral; Oral |
Strength | 500mg |
Market Status | Prescription |
Company | Pharmacia Upjohn; Pharmacia And Upjohn |
6 of 6 | |
---|---|
Drug Name | Sulfasalazine |
Drug Label | Sulfasalazine Tablets USP, 500 mg for Oral AdministrationTherapeutic classification: Anti-inflammatory agent.Chemical designation: 5-[[p-(2-Pyridylsulfamoyl)phenyl]azo]salicylic acid.Chemical Structure:The molecular weight of sulfasalazine is 398.39.... |
Active Ingredient | Sulfasalazine |
Dosage Form | Tablet; Tablet, delayed release |
Route | Oral |
Strength | 500mg |
Market Status | Prescription |
Company | Vintage Pharms; Watson Labs |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
58
PharmaCompass offers a list of Sulfasalazine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sulfasalazine manufacturer or Sulfasalazine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sulfasalazine manufacturer or Sulfasalazine supplier.
PharmaCompass also assists you with knowing the Sulfasalazine API Price utilized in the formulation of products. Sulfasalazine API Price is not always fixed or binding as the Sulfasalazine Price is obtained through a variety of data sources. The Sulfasalazine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Azopyrin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Azopyrin, including repackagers and relabelers. The FDA regulates Azopyrin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Azopyrin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Azopyrin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Azopyrin supplier is an individual or a company that provides Azopyrin active pharmaceutical ingredient (API) or Azopyrin finished formulations upon request. The Azopyrin suppliers may include Azopyrin API manufacturers, exporters, distributors and traders.
click here to find a list of Azopyrin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Azopyrin DMF (Drug Master File) is a document detailing the whole manufacturing process of Azopyrin active pharmaceutical ingredient (API) in detail. Different forms of Azopyrin DMFs exist exist since differing nations have different regulations, such as Azopyrin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Azopyrin DMF submitted to regulatory agencies in the US is known as a USDMF. Azopyrin USDMF includes data on Azopyrin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Azopyrin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Azopyrin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Azopyrin Drug Master File in Japan (Azopyrin JDMF) empowers Azopyrin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Azopyrin JDMF during the approval evaluation for pharmaceutical products. At the time of Azopyrin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Azopyrin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Azopyrin Drug Master File in Korea (Azopyrin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Azopyrin. The MFDS reviews the Azopyrin KDMF as part of the drug registration process and uses the information provided in the Azopyrin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Azopyrin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Azopyrin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Azopyrin suppliers with KDMF on PharmaCompass.
A Azopyrin CEP of the European Pharmacopoeia monograph is often referred to as a Azopyrin Certificate of Suitability (COS). The purpose of a Azopyrin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Azopyrin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Azopyrin to their clients by showing that a Azopyrin CEP has been issued for it. The manufacturer submits a Azopyrin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Azopyrin CEP holder for the record. Additionally, the data presented in the Azopyrin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Azopyrin DMF.
A Azopyrin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Azopyrin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Azopyrin suppliers with CEP (COS) on PharmaCompass.
A Azopyrin written confirmation (Azopyrin WC) is an official document issued by a regulatory agency to a Azopyrin manufacturer, verifying that the manufacturing facility of a Azopyrin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Azopyrin APIs or Azopyrin finished pharmaceutical products to another nation, regulatory agencies frequently require a Azopyrin WC (written confirmation) as part of the regulatory process.
click here to find a list of Azopyrin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Azopyrin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Azopyrin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Azopyrin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Azopyrin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Azopyrin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Azopyrin suppliers with NDC on PharmaCompass.
Azopyrin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Azopyrin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Azopyrin GMP manufacturer or Azopyrin GMP API supplier for your needs.
A Azopyrin CoA (Certificate of Analysis) is a formal document that attests to Azopyrin's compliance with Azopyrin specifications and serves as a tool for batch-level quality control.
Azopyrin CoA mostly includes findings from lab analyses of a specific batch. For each Azopyrin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Azopyrin may be tested according to a variety of international standards, such as European Pharmacopoeia (Azopyrin EP), Azopyrin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Azopyrin USP).